Issue 10, 2024

Photothermal therapy: a novel potential treatment for prostate cancer

Abstract

Prostate cancer (PCa) is a leading cause of cancer-related death in men, and most PCa patients treated with androgen deprivation therapy will progress to metastatic castration-resistant prostate cancer (mCRPC) due to the lack of efficient treatment. Recently, lots of research indicated that photothermal therapy (PTT) was a promising alternative that provided an accurate and efficient prostate cancer therapy. A photothermic agent (PTA) is a basic component of PPT and is divided into organic and inorganic PTAs. Besides, the combination of PTT and other therapies, such as photodynamic therapy (PDT), immunotherapy (IT), chemotherapy (CT), etc., provides an more efficient strategy for PCa therapy. Here, we introduce basic information about PTT and summarize the PTT treatment strategies for prostate cancer. Based on recent works, we think the combination of PPT and other therapies provides a novel possibility for PCa, especially CRPC clinical treatment.

Graphical abstract: Photothermal therapy: a novel potential treatment for prostate cancer

Article information

Article type
Review Article
Submitted
11 jan 2024
Accepted
09 mar 2024
First published
09 abr 2024

Biomater. Sci., 2024,12, 2480-2503

Photothermal therapy: a novel potential treatment for prostate cancer

Z. Dong, K. Xue, A. Verma, J. Shi, Z. Wei, X. Xia, K. Wang and X. Zhang, Biomater. Sci., 2024, 12, 2480 DOI: 10.1039/D4BM00057A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements